Eastman Chemical Co. (EMN) financials: revenue, earnings and cash flow
Fiscal 2016–2025 + TTM · from SEC filings · data as of November 16, 2026
Summary
Eastman Chemical’s revenue went from $9.0B in fiscal 2016 to $8.8B in fiscal 2025, a decline of about 0.3% a year.
Net income in fiscal 2025 was $474M, a net margin of 5.4%; the best year in this period was 2017 with $1.4B.
Over the twelve months to September 30, 2026, revenue was $9.0B and net income $625M.
Free cash flow was $424M in fiscal 2025 and positive in 10 of the 10 years shown.
The diluted share count fell 22% over the period (buybacks).
Revenue, profit and cash flow by year
Income statement
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $9.0B | $8.8B | $9.4B | $9.2B | $10.6B | $10.5B | $8.5B | $9.3B | $10.2B | $9.5B | $9.0B |
| Gross profit | $1.9B | $1.8B | $2.3B | $2.1B | $2.1B | $2.5B | $2.0B | $2.2B | $2.5B | $2.4B | $2.4B |
| Operating income | $653M | $568M | $1.1B | $1.1B | $977M | $1.1B | $530M | $902M | $1.3B | $1.5B | $1.4B |
| Net income | $625M | $474M | $905M | $894M | $793M | $857M | $478M | $759M | $1.1B | $1.4B | $854M |
| EPS (diluted) | $5.43 | $4.10 | $7.67 | $7.49 | $6.35 | $6.25 | $3.50 | $5.48 | $7.56 | $9.47 | $5.75 |
| R&D | $246M | $255M | $250M | $239M | $264M | $254M | $226M | $234M | $235M | $227M | $223M |
| Revenue growth | — | −6.7% | +1.9% | −13.0% | +1.0% | +23.6% | −8.6% | −8.6% | +6.3% | +6.0% | −6.6% |
Cash flow
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $879M | $970M | $1.3B | $1.4B | $975M | $1.6B | $1.5B | $1.5B | $1.5B | $1.7B | $1.4B |
| Capital spending | -$410M | -$546M | -$599M | -$828M | -$611M | -$555M | -$383M | -$425M | -$528M | -$649M | -$626M |
| Free cash flow | $469M | $424M | $688M | $546M | $364M | $1.1B | $1.1B | $1.1B | $1.0B | $1.0B | $759M |
| Dividends paid | $382M | $381M | $379M | $376M | $381M | $375M | $358M | $343M | $318M | $296M | $272M |
| Buybacks | — | — | — | — | — | $900M | — | — | — | — | — |
| Stock-based pay | $72M | $48M | $63M | $64M | $69M | $70M | $44M | $59M | $64M | $52M | $36M |
Balance sheet
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash | — | $566M | $837M | $548M | $493M | $459M | $564M | $204M | $226M | $191M | $181M |
| Debt | — | $4.8B | $5.0B | $4.8B | $5.2B | $5.2B | $5.6B | $6.0B | $6.2B | $6.5B | $6.6B |
| Equity | — | $6.0B | $5.8B | $5.5B | $5.2B | $5.7B | $6.0B | $6.0B | $5.8B | $5.4B | $4.5B |
| Total assets | — | $14.9B | $15.2B | $14.6B | $14.7B | $15.5B | $16.1B | $16.0B | $16.0B | $16.0B | $15.5B |
| Shares (diluted) | 115M | 116M | 118M | 119M | 125M | 137M | 136M | 138M | 143M | 146M | 148M |
Margins and returns
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 20.6% | 21.1% | 24.4% | 22.4% | 20.2% | 23.9% | 23.3% | 24.1% | 24.4% | 24.8% | 26.2% |
| Operating margin | 7.2% | 6.5% | 11.5% | 11.8% | 9.2% | 10.3% | 6.3% | 9.7% | 12.9% | 16.0% | 15.3% |
| Net margin | 6.9% | 5.4% | 9.7% | 9.7% | 7.5% | 8.2% | 5.6% | 8.2% | 10.6% | 14.5% | 9.5% |
| FCF margin | 5.2% | 4.8% | 7.3% | 5.9% | 3.4% | 10.2% | 12.7% | 11.6% | 10.0% | 10.6% | 8.4% |
| ROIC | — | 4.4% | 8.4% | 8.7% | 7.7% | 8.0% | 4.2% | 6.4% | 9.1% | 10.1% | 10.2% |
| ROE | — | 8.0% | 15.7% | 16.4% | 15.4% | 15.0% | 7.9% | 12.7% | 18.6% | 25.6% | 18.8% |
Frequently asked questions
What is Eastman Chemical’s annual revenue?
$8.8B in fiscal 2025 and $9.0B over the twelve months to September 30, 2026.
How much profit does Eastman Chemical make?
Net income was $474M in fiscal 2025 (net margin 5.4%).
Is Eastman Chemical’s revenue growing?
No: revenue fell 6.7% in fiscal 2025 compared with the year before.
From the company’s 10-K and 10-Q filings with the SEC; per-share figures adjusted for stock splits. Rebuilt daily. Not investment advice.